Skip to content

Effectiveness of Motivational Interviewing-based Adherence Therapy with Family Support Program on Medication Adherence for Persons with Schizophrenia: A Randomized Controlled Trial

Effectiveness of Motivational Interviewing-based Adherence Therapy with Family Support Program on Medication Adherence for Persons with Schizophrenia: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210703001
Enrollment
40
Registered
2021-07-03
Start date
2019-12-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients with schizophrenia who diagnosis of schizophrenia disorder within 5 years and a previous history of medication non-compliance. Adherence therapy, Family support, Medication Adherence, Motivational interviewing-based program, schizophrenia,

Interventions

The MIAT with family support program is combined between Cognitive Behavioral Therapy and Motivational Interviewing and integrated with Family support concept,Usual care is a normal care in mental hea
Experimental Other,No Intervention Other
MIAT with family support program,Usual care

Sponsors

Graduate School, Burapha University, Fiscal Year 2020
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of schizophrenia disorder within 5 years 2. Ages between 20 and 59 years 3. Not co-morbidities of learning disability, organic brain disease, severe cognitive impairments, drug dependence, or severe depression 4. A previous history of medication non-compliance 5. One significant family caregiver whose age ranged from 20 years and over and able to participate in the program 6. Ability to read, write, and speak Thai

Exclusion criteria

Exclusion criteria: Patients with evidence of increased psychiatric symptoms severity which impede their abilities to participate in the program

Design outcomes

Primary

MeasureTime frame
Insight into illness 1. baseline assessment (pre-test), 2.post-test at completion of the intervention (5 weeks), 3. Follow-up test at completion of the intervention (9 weeks). The Insight and Treatment Attitude Questionnaire (ITAQ) ,Adherence attitude 1. baseline assessment (pre-test), 2.post-test at completion of the intervention (5 weeks), 3. Follow-up test at completion of the intervention (9 weeks) Hogan Drug Attitude Inventory (DAI)

Secondary

MeasureTime frame
Adherence behavior 1. baseline assessment (pre-test), 2.post-test at completion of the intervention (5 weeks), 3. Follow-up test at completion of the intervention (9 weeks). Medication Adherence Questionnaire (MAQ)

Countries

Thailand

Contacts

Public ContactHengudomsub Pornpat

Burapha university

pornpat12@yahoo.com038102222

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026